Search

Find uplifting stories about heroes, innovations, and solutions

9 results for "moderna"

Moderna Pays $950M to Settle mRNA Vaccine Patent Dispute
Health & WellnessMar 4

Moderna Pays $950M to Settle mRNA Vaccine Patent Dispute

Moderna has agreed to pay Roivant up to $2.25 billion to settle a patent lawsuit over its groundbreaking Covid-19 vaccine technology. The settlement could become one of the largest in patent history while keeping life-saving vaccine innovation moving forward.

STAT News2 min read
FDA Reverses Course on Moderna's mRNA Flu Vaccine
Health & WellnessFeb 23

FDA Reverses Course on Moderna's mRNA Flu Vaccine

The FDA suddenly agreed to review Moderna's revolutionary mRNA flu vaccine after initially rejecting it just a week earlier. Meanwhile, scientists developed an inhaled vaccine that could protect against multiple respiratory illnesses at once.

Scientific American3 min read
FDA Approves Review of First mRNA Flu Vaccine
Health & WellnessFeb 20

FDA Approves Review of First mRNA Flu Vaccine

The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.

Google News - Business2 min read
FDA Reverses Decision, Will Review Moderna's mRNA Flu Shot
Health & WellnessFeb 19

FDA Reverses Decision, Will Review Moderna's mRNA Flu Shot

After an unexpected rejection last week, the FDA has reversed course and agreed to review Moderna's new mRNA flu vaccine. Seniors could have a new option to protect against the flu by late 2026.

Ars Technica2 min read
FDA Will Review Moderna's mRNA Flu Vaccine After All
Health & WellnessFeb 19

FDA Will Review Moderna's mRNA Flu Vaccine After All

After rejecting Moderna's flu vaccine application just a week ago, the FDA reversed course and will now review the promising mRNA shot. The new technology could revolutionize how we protect ourselves from seasonal flu.

Scientific American2 min read
UK Approves First Homegrown mRNA Vaccine at New Facility
InnovationFeb 11

UK Approves First Homegrown mRNA Vaccine at New Facility

Britain just approved its first domestically manufactured mRNA vaccine, marking a major milestone in pandemic preparedness. The new Moderna facility in Oxfordshire can produce up to 250 million doses per year during health emergencies.

Independent UK - Good News2 min read
🧘
Health & WellnessFeb 11

Mexico to Produce mRNA Vaccines with Moderna Deal

Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.

Mexico News Daily2 min read
Melanoma Vaccine Cuts Cancer Return Risk by 49% in Trial
Health & WellnessJan 21

Melanoma Vaccine Cuts Cancer Return Risk by 49% in Trial

A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.

Euronews2 min read
Moderna Skin Cancer Treatment Shows Lasting Benefits
Health & WellnessJan 20

Moderna Skin Cancer Treatment Shows Lasting Benefits

A Moderna immunotherapy for melanoma continues to protect patients years after treatment, new data shows. The results bring hope for a cancer vaccine that could change how we fight one of the deadliest skin cancers.

STAT News2 min read